Related Experiment Videos
Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy
D H Zangen1, S Bonner-Weir, C H Lee
1Joslin Diabetes Center and the Department of Medicine, Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, USA. zangend@joslab.harvard.edu.
Abstract:
Reduction of GLUT2 is associated with loss of glucose-induced insulin secretion in genetic and chemical diabetes and in transplanted islets exposed to chronic hyperglycemia. To examine the mechanisms for this loss of GLUT2 in normal islets exposed to hyperglycemia, we performed studies on Sprague Dawley rats 4 weeks after a 90% partial pancreatectomy (Px), a well-characterized model of hyperglycemia. GLUT2 immunofluorescence in the beta-cell of Px rats was greatly reduced. Western blot analysis of homogenates of isolated Px islets also showed a reduction in GLUT2 protein; densitometry measurements were 36 +/- 3% of values from islets of sham-operated controls. Insulin protein levels were decreased to a similar extent. Islet GLUT2 and insulin mRNA were measured with quantitative reverse transcriptase-polymerase chain reaction. The level of GLUT2 mRNA from Px islets was 24 +/- 4% of that of islets from sham-operated controls; similar results were obtained for insulin. Because both these beta-cell-specific messages were reduced, we analyzed the Px islets for the pancreas-duodenum-specific transcription factor IDX-1(IPF-1, STF-1, PDX-1) protein. It was markedly reduced (approximately 80%) in islets from the Px rats. These data suggest that 1) the loss of GLUT2 protein associated with hyperglycemia is at least partially explained by reduced levels of the GLUT2 gene transcripts; 2) the reduction of beta-cell insulin content during chronic hyperglycemia may not be completely due to degranulation (reduced levels of gene transcripts may play a role); and 3) the reduction in the transcription factor IDX-1 raises the possibility that dysregulation of transcription factors may contribute to the abnormal beta-cell function found in states of chronic hyperglycemia.
Insights
Chronic hyperglycemia reduces glucose transporter 2 (GLUT2) and insulin in pancreatic beta-cells. This is linked to decreased GLUT2 gene expression and the transcription factor IDX-1, impacting insulin secretion.
Area of Science:
- Endocrinology
- Molecular Biology
- Diabetes Research
Background:
- Reduced glucose transporter 2 (GLUT2) is linked to impaired insulin secretion in diabetes.
- Chronic hyperglycemia is a key factor in diabetes complications.
Purpose of the Study:
- To investigate the mechanisms behind GLUT2 reduction in pancreatic islets under hyperglycemic conditions.
- To explore the role of transcription factors in hyperglycemia-induced beta-cell dysfunction.
Main Methods:
- Utilized a rat model of chronic hyperglycemia (90% partial pancreatectomy).
- Assessed GLUT2 and insulin protein levels using immunofluorescence and Western blot.
- Quantified GLUT2 and insulin mRNA levels via reverse transcriptase-polymerase chain reaction.
- Measured the expression of the transcription factor IDX-1 in pancreatic islets.
Main Results:
- Partial pancreatectomy significantly reduced GLUT2 and insulin protein levels in pancreatic islets.
- Both GLUT2 and insulin mRNA levels were markedly decreased in hyperglycemic rats.
- A substantial reduction (approximately 80%) in the transcription factor IDX-1 was observed.
Conclusions:
- Hyperglycemia-induced loss of GLUT2 is partly due to reduced GLUT2 gene transcripts.
- Decreased insulin content in hyperglycemia may involve reduced gene expression, not just degranulation.
- Reduced IDX-1 suggests transcription factor dysregulation contributes to beta-cell dysfunction in chronic hyperglycemia.